$PBIO Cannaworx and its principals have twelve products being readied for market launch over the coming year. These include two novel products that utilize the company's patented/patent pending, full and partial spectrum, hemp-derived phytocannabinoid formulations for pain relief. Cannaworx plans to launch these two products in the coming months with a pain indication allowed under an FDA OTC monograph. At that time, the company believes these products will be the only oral, hemp-derived phytocannabinoid-containing products available on the market with such a claim. (www.cannaworx.io).
https://seekingalpha.com/pr/17876249-pressure...-intent-to
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!